KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -57.1% | 12,592 | -11.5% | 0.00% | – |
| Q2 2023 | $35 | -98.7% | 14,225 | -98.3% | 0.00% | -100.0% |
| Q1 2023 | $2,594 | +96.5% | 829,034 | +342.2% | 0.00% | 0.0% |
| Q4 2022 | $1,320 | -99.9% | 187,491 | +22.4% | 0.00% | 0.0% |
| Q3 2022 | $1,319,000 | +3897.0% | 153,214 | +3706.6% | 0.00% | – |
| Q2 2022 | $33,000 | -67.6% | 4,025 | -34.5% | 0.00% | – |
| Q1 2022 | $102,000 | -92.8% | 6,149 | -92.8% | 0.00% | – |
| Q4 2021 | $1,420,000 | +412.6% | 84,924 | +165.4% | 0.00% | – |
| Q3 2021 | $277,000 | +127.0% | 31,999 | +42.9% | 0.00% | – |
| Q2 2021 | $122,000 | -53.8% | 22,385 | -49.6% | 0.00% | – |
| Q1 2021 | $264,000 | +78.4% | 44,375 | +56.7% | 0.00% | – |
| Q4 2020 | $148,000 | -4.5% | 28,310 | -11.9% | 0.00% | – |
| Q3 2020 | $155,000 | -11.4% | 32,116 | -5.3% | 0.00% | – |
| Q2 2020 | $175,000 | +41.1% | 33,918 | +19.8% | 0.00% | – |
| Q1 2020 | $124,000 | -8.1% | 28,306 | -16.3% | 0.00% | – |
| Q4 2019 | $135,000 | +58.8% | 33,813 | +30.4% | 0.00% | – |
| Q3 2019 | $85,000 | -56.0% | 25,939 | +3.6% | 0.00% | – |
| Q2 2019 | $193,000 | +206.3% | 25,037 | +603.7% | 0.00% | – |
| Q1 2019 | $63,000 | +53.7% | 3,558 | +84.6% | 0.00% | – |
| Q3 2018 | $41,000 | – | 1,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |